Literature DB >> 11508600

Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis.

M Harjacek1, S Diaz-Cano, M De Miguel, H Wolfe, C A Maldonado, G A Rabinovich.   

Abstract

OBJECTIVE: Juvenile idiopathic arthritis (JIA) is characterized by hyperplasia of synovial cells and accumulation of mononuclear inflammatory infiltrates, which are locally maintained through a balance between cell proliferation and apoptosis. Although defective clearance of activated T cells in RA joints has been explained by alterations of the Fas-Fas ligand system, this has not been confirmed in synovial tissue of patients with JIA. We evaluated the relation between expression of galectin-1 (Gal-1) and galectin-3 (Gal-3) (beta-galactoside-binding proteins with pro- and anti-apoptotic properties, respectively) and the apoptosis and proliferation rates of infiltrative lymphocytes in synovial tissue of patients with JIA.
METHODS: Using slide cytometry and in situ end labeling we observed dysregulated apoptosis of infiltrating mononuclear cells within the synovial tissue of patients with JIA.
RESULTS: Patients with pauciarticular JIA showed minimal apoptosis, high Bcl-2 expression, and high or normal proliferation rates, while patients with polyarticular disease showed the lowest apoptotic indexes, accompanied by low Bcl-2 expression and low proliferation rates. We found that Gal-1 expression is downregulated and Gal-3 expression is upregulated in synovial tissue from patients with JIA.
CONCLUSION: In patients with polyarticular JIA, accumulation of inflammatory cells is mainly due to downregulated apoptosis, whereas in patients with pauciarticular disease the process results from increased proliferation. Defective mononuclear apoptosis in synovial inflammatory infiltrates from patients with JIA could be explained in part by decreased Gal-1 and increased Gal-3 expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508600

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  24 in total

Review 1.  Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses.

Authors:  Gabriel A Rabinovich; Marta A Toscano; Juan M Ilarregui; Natalia Rubinstein
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 2.  The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders.

Authors:  J M Ilarregui; G A Bianco; M A Toscano; G A Rabinovich
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

3.  Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase.

Authors:  Mercedes B Fuertes; Luciana L Molinero; Marta A Toscano; Juan M Ilarregui; Natalia Rubinstein; Leonardo Fainboim; Norberto W Zwirner; Gabriel A Rabinovich
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

4.  Disease-specific proteins from rheumatoid arthritis patients.

Authors:  Choong Won Kim; Eun Hye Cho; Yun Jong Lee; Yoon Hee Kim; Young Sool Hah; Deok Ryong Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

5.  Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice.

Authors:  Daniela Paclik; Uta Berndt; Claudia Guzy; Anja Dankof; Silvio Danese; Pamela Holzloehner; Stefan Rosewicz; Bertram Wiedenmann; Bianca M Wittig; Axel U Dignass; Andreas Sturm
Journal:  J Mol Med (Berl)       Date:  2007-12-07       Impact factor: 4.599

6.  Expression of galectins-1, -3 and -4 varies with strain and type of experimental colitis in mice.

Authors:  Anne Mathieu; Nathalie Nagy; Christine Decaestecker; Liesbeth Ferdinande; Klaas Vandenbroucke; Pieter Rottiers; Claude A Cuvelier; Isabelle Salmon; Pieter Demetter
Journal:  Int J Exp Pathol       Date:  2008-12       Impact factor: 1.925

Review 7.  BH3-only proteins in rheumatoid arthritis: potential targets for therapeutic intervention.

Authors:  J Hutcheson; H Perlman
Journal:  Oncogene       Date:  2008-12       Impact factor: 9.867

8.  Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways.

Authors:  Andrew Filer; Magdalena Bik; Greg N Parsonage; John Fitton; Emily Trebilcock; Katherine Howlett; Michelle Cook; Karim Raza; David L Simmons; Andrew M C Thomas; Mike Salmon; Dagmar Scheel-Toellner; Janet M Lord; Gabriel A Rabinovich; Christopher D Buckley
Journal:  Arthritis Rheum       Date:  2009-06

9.  Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signalling.

Authors:  Li Liu; Takashi Sakai; Nobuya Sano; Kiyoshi Fukui
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

Review 10.  Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation.

Authors:  Gabriel A Rabinovich; Marta A Toscano
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.